Using Virtual Reality & Sensor Technology to Enhance Outcomes From

Status Completed

Clinical Trial Summary

This study evaluates whether virtual-reality-based inhibitory control trainings are more effective than computerized trainings in reducing binge eating symptomatology. These trainings are used to improve people's ability to resist their impulses towards highly palatable foods (such as chips or cookies). These trainings also offer promise as a companion to Cognitive Behavioral Therapy, an often used and relatively effective therapeutic methodology.

Clinical Trial Description

Low levels of inhibitory control (i.e., the ability to withhold a quick, automatic response) is strongly linked with binge eating pathology. One of the most widely used and effective treatments for binge eating leaves 40-60% of patients partially or fully symptomatic at post-treatment. Researchers have begun to investigate the efficacy of computerized inhibitory control trainings (ICTs), which are tasks in which participants are asked repeatedly withhold a keypress responses to food stimuli. The intention of these trainings is to improve inhibitory control and to, in turn, reduce dysregulated eating behavior. Results for the efficacy of ICTs are promising, yet mixed. ICTs that are gamified (i.e., turned into a video game) using virtual reality technology have high potential to address the barriers which may be limiting the efficacy of previous ICTs. The current study aims to finalize development and test the feasibility, acceptability and preliminary efficacy of the first-ever virtual reality ICT (VR-ICT) for individuals with binge eating pathology. Thus, the study's aims are as follows: Primary aim 1: Enhance features of a previously developed, VR-based ICT for binge eating. Primary aim 2: Examine the feasibility and acceptability of the VR ICT training program. Primary aim 3: Examine the efficacy of VR-ICT versus a non-VR ICT and ICT vs. sham training, for reductions in binge eating from pre to post-treatment and at follow-up. Based on previous research and data from a pilot study, the investigators hypothesize a) that the VR ICT training program will be feasible and acceptable and b) that the VR-ICT and ICT will produce superior reductions in binge eating from pre- to post-treatment and at follow-up, as compared, respectively, with the non-VR ICT and the sham ICT. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05041660
Study type	Interventional
Source	Drexel University
Contact
Status	Completed
Phase	N/A
Start date	October 14, 2019
Completion date	August 5, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04038190` - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course	Phase 2
Terminated	`NCT04278755` - Binge Eating & Birth Control	Phase 2
Completed	`NCT00537810` - Treatment of Binge Eating in Obese Patients in Primary Care	Phase 4
Recruiting	`NCT05509257` - Naltrexone Neuroimaging in Teens With Eating Disorders	Early Phase 1
Completed	`NCT03687658` - Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating	N/A
Recruiting	`NCT05937243` - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating	N/A
Completed	`NCT00607789` - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression	Phase 4
Completed	`NCT04117542` - Working Memory in Overweight Children With and Without Loss of Control Eating
Recruiting	`NCT04211818` - Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE)	N/A
Completed	`NCT03429114` - Emotion Regulation in Binge Eating and Purging Among Adolescents
Completed	`NCT03007459` - The Health of Competitive Fitness Athletes
Completed	`NCT02180984` - The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED	N/A
Completed	`NCT00829283` - Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care	N/A
Completed	`NCT00307619` - An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.	Phase 3
Active, not recruiting	`NCT04127214` - The ITA Model of Integrated Treatment of Eating Disorders
Not yet recruiting	`NCT06129461` - A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy	N/A
Recruiting	`NCT05177705` - The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement	Early Phase 1
Recruiting	`NCT02716831` - Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating	N/A
Completed	`NCT03850288` - Inhibitory Control and Eating Disorders
Completed	`NCT00680979` - Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms